Advanced therapy medicinal products (ATMPs) are a dynamic and current topic for
healthcare systems, with new products progressing to market at an increasing rate. ATMPs …

Background: Advanced therapy medicinal products (ATMPs) are innovative therapies that
encompass gene therapy, somatic cell therapy, and tissue-engineered products. These …

This review discusses the methodological challenges to the evaluation of advanced therapy
medicinal products (ATMPs) by the UK National Institute for Health and Care Excellence …

Recent advances in biomedicine are opening the door to new approaches, and treatment
and prevention are being transformed by novel medicines based on genetic engineering …

Objectives Advanced-therapy medicinal products (ATMPs), such as gene therapy, cell
therapy and tissue engineering are a new class of medicines in the EU. ATMPs offer …

Introduction: Advanced Therapy Medicinal Products are a type of therapies that, in some
cases, hold great potential for patients without an effective current therapeutic approach but …

Background Advanced therapy medicinal products (ATMPs) represent an important
cornerstone for innovation in healthcare. However, uncertainty on the value, the high …

Background Advanced therapy medicinal products (ATMPs) are beginning to reach
European markets, and questions are being asked about their value for patients and how …

The emergence of advanced therapy medicinal products (ATMPs), a disruptive class of
health technologies, is generating important challenges in terms of value assessment and …

Background Advanced therapy medicinal products (ATMPs) are innovative therapies likely
associated with high prices. Payers need guidance to create a balance between ensuring …